Meta-analysis of β-blockers in heart failure -: Reply

被引:0
|
作者
Cleophas, TJM [1 ]
机构
[1] Albert Schweitzer Hosp, NL-3300 AH Dordrecht, Netherlands
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:562 / 563
页数:2
相关论文
共 50 条
  • [21] Beta blockers in systolic heart failure - Reply
    Jackowski, Leslie
    Azam, Roshmeen
    AUSTRALIAN FAMILY PHYSICIAN, 2008, 37 (06) : 391 - 391
  • [22] Beta blockers for congestive heart failure - Reply
    Buchanan, A
    Tan, RS
    POSTGRADUATE MEDICINE, 1998, 103 (02) : 25 - 26
  • [23] Prescription of beta blockers in heart failure - Reply
    Rodriguez Roca, G. C.
    Barrios Alonso, V.
    Llisterri Caro, J. L.
    Alonso Moreno, F. J.
    REVISTA CLINICA ESPANOLA, 2008, 208 (02): : 112 - 113
  • [24] Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis"
    Zito, Andrea
    Restivo, Attilio
    D'Amario, Domenico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 397
  • [25] Beta-blockers for primary prevention of heart failure in patients with hypertension - Insights from a meta-analysis
    Bangalore, Sripal
    Wild, David
    Parkar, Sanobar
    Kukin, Marrick
    Messerli, Franz H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (13) : 1062 - 1072
  • [26] Meta-analysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure
    Cleophas, TJ
    van Marum, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (04): : 487 - +
  • [27] Prevention of onset of atrial fibrillation by beta-blockers treatment in heart failure. A meta-analysis
    Abi-Nasr, I.
    Bouzamondo, A.
    Hulot, J. S.
    Lechat, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 884 - 884
  • [28] Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.
    Kotecha D.
    Manzano L.
    Altman D.G.
    Krum H.
    Erdem G.
    Williams N.
    Flather M.D.
    Beta-Blockers in Heart Failure Collaborative Group
    Systematic Reviews, 2 (1) : 7
  • [29] Beta blockers for the prevention of sudden cardiac death in heart failure: a meta-analysis of randomized controlled trials
    Al-Gobari, M.
    Pillon, F.
    Gueyffier, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 113 - 113
  • [30] Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure Reply
    van der Meer, P.
    van Veldhuisen, D. J.
    HEART, 2009, 95 (15) : 1279 - 1279